<DOC>
	<DOCNO>NCT02794506</DOCNO>
	<brief_summary>Background : Propolis natural resin make bee various plant source . Propolis exert antimicrobial , anti-inflammatory , immunomodulatory , antioxidant , antidiabetic property . The purpose study assess adjunctive benefit propolis supplementation individual chronic periodontitis type 2 diabetes mellitus ( T2DM ) receive scale root planing ( SRP ) . Methods : A 6-month randomized blind clinical trial compare SRP placebo ( placebo+SRP group , n=26 ) combine 6- month regimen 400 mg oral propolis daily ( propolis+SRP group , n=26 ) perform patient long-standing T2DM chronic periodontitis . Treatment outcomes include hemoglobin A1c ( HbA1c ) , fast plasma glucose ( FPG ) , serum N€- ( carboxymethyl ) lysine ( CML ) change periodontal parameter .</brief_summary>
	<brief_title>Propolis Improves Glycemic Control Subjects With Type 2 Diabetes Chronic Periodontitis</brief_title>
	<detailed_description>INTRODUCTION Diabetes mellitus ( DM ) metabolic disorder characterize frequent period hyperglycemia , induce certain molecular pathway seem crucial initiation angiopathic complication DM . Several mechanism suggest explain pathogenicity complication hyperglycemia protein kinase C isoforms , enhance polyol pathway flux , increase accumulation advance glycosylated end-products . A dysregulated immune response stem inappropriate cytokine production possible mechanism underpin cross-susceptibility periodontal disease DM . DM unambiguously determine one major risk factor periodontitis . It report risk periodontitis increase almost threefold diabetic patient compare healthy individual . The glycemic control level believe paramount importance determinant increase risk develop complication . Diabetic patient HbA1c level 9 % find increase prevalence advance chronic periodontitis comparison healthy people accord US National Health Nutrition Examination Survey ( NHANES ) III . Two decade ago , periodontitis add represent sixth complication DM . Individuals suffer periodontal disease often increase serum level proinflammatory cytokine , IL-1 , IL-6 TNF-α . Diabetic patient periodontitis possess hyperinflammatory immune cell lead enhance release proinflammatory cytokine , eventually lead insulin resistance result great risk poor glycemic control compare diabetic patient without periodontitis . The accumulation irreversible advanced glycation end-products ( AGEs ) , predominantly N€- ( carboxymethyl ) lysine ( CML ) show alter cell function tissue structure . Due difficulty manage diabetes ; critical need new therapeutic modality prevention diabetes-related complication . Propolis natural resin synthesize honey bee substance extract part plant , bud sap . Due physical characteristic , propolis utilize honey bee protect hive foreign invader . Propolis use century homeopathic medicine know anti-inflammatory property , especially Europe ancient Egypt . It traditionally use management numerous disease , gastrointestinal disorder mucocutaneous infection fungal , bacterial viral etiology . There several type propolis differ composition depend plant source varies accord geographic zone Brazil , Peru , China Europe . Propolis contain 230 constituent , include flavonoid , cinnamic acid ester , caffeic acid caffeic acid phenethyl ester . It find wide array biological activity , include antibacterial , antiviral , fungicidal , anti-inflammatory , antioxidant , hepatoprotective , free radical scavenging , immunomodulatory anti-diabetic activity . Recently , investigation reveal caffeic acid phenethyl ester ( CAPE ) important active molecule find propolis responsible therapeutic property . The action Chinese Brazilian propolis streptozotocin-induced type 1 diabetes mellitus Sprague Dawley rat explore result indicate type propolis significantly inhibit body weight loss plasma glucose increase experimental rat . Additionally , rat treat Chinese propolis exhibit 8.4 % reduction HbA1c level comparison non-treated diabetic group . Hence , hypothesize periodontal therapy SRP conjunction oral daily supplementation propolis patient chronic periodontitis T2DM might improve diabetic periodontal outcome . Thus , aim current study evaluate whether adjunctive therapy oral propolis supplementation SRP compare SRP plus placebo , reduces glycated hemoglobin improves clinical periodontal parameter 6 month therapy individual chronic periodontitis T2DM . MATERIALS AND METHODS Study Population : The study approve Institutional Review Board Mansoura University . Subjects select recall maintenance visit Internal Medicine Hospital , Mansoura University , June December 2014 . Patients fill questionnaire gather information dental oral health care follow periodontal screening examination determine eligible individual . Patients consider eligible study T2DM minimum five year duration take stable dos oral hypoglycemic drug and/or insulin least 6 month . In addition , chronic periodontitis probe pocket depth clinical attachment loss ≥ 5 mm detectable bleed probe least one site sextant . Patients minimum 20 teeth select . All patient diagnose moderate severe chronic periodontitis accord Armitage criterion ( 24 ) . Exclusion criterion include smoker , recent extend use antibiotic non-steroidal anti-inflammatory drug within last 3 month , patient periodontal therapy within one year , patient grade 3 4 retinopathy , pregnancy woman use oral contraceptive . Enrolled patient sign write informed consent study participation . Study Design : Fifty two people T2DM diagnose moderate severe chronic periodontitis randomly assign use computer-generated random table receive propolis ( 400 mg capsule orally daily six month ) adjuvant scale root planing ( Propolis+ SRP group , n = 26 ) , match placebo capsule 6 month addition scale root planing ( Placebo+SRP group , n = 26 ) parallel randomize blind controlled trial allocation ratio = 1:1 . The generated allocation sequence conceal close stapled envelope intervention assign . Investigators involve randomization . Propolis commercially name BioPropolis ( Sigma Pharmaceutical Industries International Business Establishment Co. IBE Pharma , Cairo , Egypt ) match placebo capsule use study . All participant group assign receive equal number capsule 6- month period . Vials contain propolis placebo drug label specific code unknown patient investigator . Patients instruct take one capsule daily give vial . Patient compliance calculate count remain capsule return vial every month . Untoward side effect medication query record visit study period . All individual receive meticulous full mouth scale root planing ( SRP ) hand curettes ultrasonic tip local anesthesia root surface smooth clinician ( MA ) single visit . Oral hygiene instruction motivation proper tooth brush dental floss give patient . Chlohexidine 0.12 % mouthrinse prescribe patient two week SRP . Clinical Periodontal Measurements : Clinical periodontal parameter include probe pocket depth ( PD ) , clinical attachment level ( CAL ) ( distance CEJ base pocket ) , Eastman interdental bleeding ( EIBI ) , gingival ( GI ) plaque ( PI ) index assess baseline , 3 month 6 month therapy examiner ( HE ) . Intra-examiner calibration achieve examination 10 patient twice , 24 hour apart start study . Calibration accept measurement PD CAL ( use UNC-15 probe ) baseline 24 hour similar 1 mm 90 % level . Collection analysis Blood : 10 mL venous blood antecubital vein participant collect heparinized vacutainer tube baseline , 3 month 6 month treatment . Measurements HbA1c carry via automate affinity chromatography system ( Bio-Rad Micromat II , Hercules , CA ) . Fasting plasma glucose level ( FPG ) measure standard glucose oxidase method . The serum concentration N€- ( carboxymethyl ) lysine ( CML ) assess N€- ( carboxymethyl ) lysine ( CML ) ELISA Kit CML protein adduct ( OxiSelect™ , Catalog Number STA-316 , Cell Biolabs Inc. , San Diego , CA , USA ) . The amount CML adduct protein sample evaluate compare absorbance know CML-BSA standard curve describe manufacturer . Study outcomes : The primary outcome present clinical trial change HbA1c level 6 month therapy . Secondary outcome include change HbA1c level 3 month addition amount CAL gain , PD reduction change FPG serum CML level 3 6 month therapy . Statistical Analysis : A power analysis perform commencement trial type I error α = 0.05 , β = 0.14 ( 1-β ) = 0.86 . The power calculate p = 0.8641 estimate minimum sample size require find 20 per group achieve power 80 % base achievement 6-month reduction HbA1c test group control 0.8 % . All data explore use Kolmogrov-Smirnov test normality . Parametric data present mean ± SD . Baseline comparison make use Student 's t-test . One-way analysis variance ( ANOVA ) Holm-Sidak post hoc correction multiple comparison use determine significant change different time interval . Wilcoxon sign rank test Mann-Whitney test use detect difference per group group time . The α-level significance set 0.05.Statistical analysis calculate statistical software program ( Statistical Package Social Sciences version 19.0 , SPSS , Chicago , IL ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Propolis</mesh_term>
	<criteria>Patients type 2 diabetes mellitus minimum five year duration take stable dos oral hypoglycemic drug and/or insulin least 6 month . Patients chronic periodontitis probe pocket depth clinical attachment loss ≥ 5 mm detectable bleed probe least one site sextant . Patients minimum 20 teeth select . All patient diagnose moderate severe chronic periodontitis accord Armitage criterion . Smokers . Recent extend use antibiotic nonsteroidal antiinflammatory drug within last 3 month . Patients periodontal therapy within one year . Patients grade 3 4 retinopathy . Pregnancy . Women use oral contraceptive .</criteria>
	<gender>All</gender>
	<minimum_age>38 Years</minimum_age>
	<maximum_age>63 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Chronic periodontitis</keyword>
	<keyword>Propolis</keyword>
</DOC>